CLINUVEL PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.01 AUD | +1.01% |
|
-2.02% | -6.19% |
| 29/04 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
| 14/03 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Biopharmaceuticals | +1.01% | -2.02% | -6.19% | -24.46% | -38.73% | 492M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
- Comparison Chart